Dr. Song at the University of Colorado has developed a new technology that allows heart muscle regeneration by converting fibroblasts into cardiomyocytes in situ via gene therapy. Using the new method, about 60% of fibroblasts express cardiac Troponin T (cTnT) and about 50% express α-actinin. Beating cardiomyocytes are observed in less than 2 weeks. Dr. Song also effectively converted fibroblasts into cardiomyocytes in an intact beating rodent heart using an adeno-associated virus-based gene delivery method.
Download Summary Document Here:
http://cuamc.technologypublisher.com/files/sites/cu3770h_ncs.pdf